An oral insulin drug to prevent type 1 (a.k.a. juvenile) diabetes is now in clinical trials at Children's Hospital of Pittsburgh of UPMC. Scientists say the capsules could ultimately delay or even prevent the onset of juvenile diabetes in high-risk patients. Children under the age of five develop type 1 diabetes at a higher rate than any other age group. If not properly treated (with insulin injections and a proper diet), type 1 diabetes is potentially life threatening. For more on the Children's Hospital study, click here. To read the story of one family's struggle with juvenile diabetes, click here.